Market Snapshot

BSE Sensex: 77100.47 0.14%
BSE 500: 36133.32 -0.05%
BSE 200: 11237.3 0.04%
BSE 100: 25618.46 0.14%
BSE BANKEX: 65599.62 0.03%
BSE IT: 26650.91 -0.88%
Nifty 50: 24056 0.14%
Nifty 500: 23113.7 -0.05%
Nifty 200: 13891.25 0.01%
Nifty 100: 25114.1 0.15%
Nifty Midcap 100: 61795.5 -0.55%
Nifty Small 100: 18790.35 -0.47%
Nifty IT: 27330.85 -0.86%
Nifty PSU Bank: 8636.1 0.09%

News:

Refex Industries bags Rs 21-cr...
BEML bags export contract for ...
Aether Industries commences co...
Dr Reddy?s Labs receives seven...
ONGC appoints Anupam Agarwal a...

Venmax Drugs & Pharmaceuticals Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

25 Jun 2026 | 03:59 PM

18.26

-1.61 (-8.10%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-29.96%

Return (1Y)

Underperformed BSE Sensex by 23.12%
More Volatile

3.83%

Standard Deviation (1Y)

Higher than BSE Sensex by 2.99%
Consistent Performer

7/12

Months

beaten BSE Sensex
AxisDirect View

No View

52 Week High-Low

37

17

News & Announcements

Venmax Drugs & Pharmaceuticals standalone net profit declines 85.90% in the March 2026 quarter

42 days ago

Venmax Drugs & Pharmaceuticals to announce Quarterly Result
50 days ago

Venmax Drugs & Pharmaceuticals to announce Quarterly Result

07 - May - 2026 12:00 | 50 days ago

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 May 2026.
Venmax Drugs & Pharmaceuticals reports standalone net profit of Rs 0.03 crore in the December 2025 quarter
139 days ago

Venmax Drugs & Pharmaceuticals reports standalone net profit of Rs 0.03 crore in the December 2025 quarter

07 - Feb - 2026 12:00 | 139 days ago

Net profit of Venmax Drugs & Pharmaceuticals reported to Rs 0.03 crore in the quarter ended December 2025 as against net loss of Rs 0.50 crore during the previous quarter ended December 2024. Sales rose 675.00% to Rs 1.55 crore in the quarter ended December 2025 as against Rs 0.20 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 1.55 0.20 675

OPM % -1.94 -250.00 -

PBDT 0.04 -0.50 LP

PBT 0.04 -0.50 LP

NP 0.03 -0.50 LP

Powered by Capital Market - Live News
Venmax Drugs & Pharmaceuticals announces board meeting date
146 days ago

Venmax Drugs & Pharmaceuticals announces board meeting date

31 - Jan - 2026 12:00 | 146 days ago

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 February 2026.
Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

Venmax Drugs & Pharmaceuticals Ltd is trading very close to its 52 Week Low
Promoter shareholding in Venmax Drugs & Pharmaceuticals Ltd has decreased by -8.82% since past 3 Months
Promoter shareholding in Venmax Drugs & Pharmaceuticals Ltd has decreased by -40.35% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60